TL

The Lancet Diabetes & Endocrinology

The Lancet Diabetes & Endocrinology is a medical journal focused on diabetes and endocrinology. It has ISSN 2213-8587 and reports an Impact Factor of 41.8, a CiteScore of 64.2, and a 5-Year Impact Factor of 41.7.

Looking to publish in The Lancet Diabetes & Endocrinology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Endocrinology & Metabolism
Impact Factor 41.8
Quartile Q1
Open Access Type Hybrid
ISSN 2213-8587
eISSN 2213-8595
Invitation Only No

Submission Instructions

The Lancet Diabetes & Endocrinology accepts the following article types. Click on an article type to view submission instructions.

Article

Cover Letter A covering letter must be included in the submission. Cover letter must state if the research is planned for presentation at a conference.
Abstract Abstract requirements are not specified.
Manuscript Manuscript must include a research in context panel, declaration of interests statements, and source of funding statements.
References References requirements are not specified.
Figures & Tables The manuscript including tables and panels must be included in the submission, and figures must be included in the submission.
Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Review

Cover Letter A covering letter must be included in the submission. The cover letter must state any planned presentation of the research at a conference.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include declaration of interests statements and source of funding statements.
References References requirements are not specified.
Figures & Tables The manuscript including tables and panels must be included in the submission, and figures must be included in the submission.
Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Clinical Picture

Cover Letter A covering letter must be included in the submission. The cover letter must state if the research is planned to be presented at a conference.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include declaration of interests and source of funding statements.
References References requirements are not specified.
Figures & Tables The manuscript including tables and panels must be included in the submission, and figures must be included in the submission.
Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Clinical Rounds

Cover Letter A covering letter must be included in the submission. The cover letter must state any planned presentation of the research at a conference.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include declaration of interests statements and source of funding statements.
References References requirements are not specified.
Figures & Tables The manuscript including tables and panels must be included in the submission, and figures must be included in the submission.
Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Grand Rounds

Cover Letter A covering letter must be included in the submission. The cover letter must state any plans to present the research at a conference.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include declaration of interests statements and source of funding statements.
References References requirements are not specified.
Figures & Tables The manuscript including tables and panels must be included in the submission, and figures must also be included in the submission.
Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Seminar

Cover Letter A covering letter must be included in the submission. The cover letter must state if the research is planned to be presented at a conference.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include declaration of interests and source of funding statements.
References References requirements are not specified.
Figures & Tables The manuscript including tables and panels must be included in the submission, and figures must be included in the submission.
Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Series

Cover Letter A covering letter must be included in the submission. The cover letter must state if the research is planned for presentation at a conference.
Abstract Abstract requirements are not specified.
Manuscript Series must include two or more evidenced reviews. The manuscript must include declaration of interests statements and source of funding statements.
References References requirements are not specified.
Figures & Tables The manuscript must include tables and panels, and figures must be included in the submission.
Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Correspondence

Cover Letter A covering letter must be included in the submission. The cover letter must state if the research is planned to be presented at a conference.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include declaration of interests statements and source of funding statements.
References References requirements are not specified.
Figures & Tables The manuscript including tables and panels must be included in the submission, and figures must be included in the submission.
Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Recent Publications

A quarter-century of progress: innovations in lipid medicine that transformed cardiovascular prevention

Lluís Masana, Josep Ribalta, Daiana Ibarretxe

10.1016/s2213-8587(26)00102-6
View Publication

Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study

John B Buse, Harpreet S Bajaj, Stine-Mathilde Dalskov, Lucienne Donaldson, Helene H Hansen Duus, Therese Wilbek Fabricius, Martin Haluzík, Ildiko Lingvay, Sue D Pedersen, Richard E Pratley, Akshay B Jain

10.1016/s2213-8587(26)00125-7
View Publication

Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study

Vanita R Aroda, Raffaella Buzzetti, Stine-Mathilde Dalskov, Akshay B Jain, Jonas Hughes Larsen, Chantal Mathieu, Richard E Pratley, Alex Videmark, Torquil Watt, John B Buse

10.1016/s2213-8587(26)00126-9
View Publication

Cagrilintide–semaglutide: a new option for patients with type 2 diabetes

André J Scheen

10.1016/s2213-8587(26)00129-4
View Publication

Correction to Lancet Diabetes Endocrinol 2026; 14: 259–74

-

10.1016/s2213-8587(26)00139-7
View Publication

Frequently asked questions

Is a cover letter required?

A covering letter should be included with the submission. Authors presenting research at a conference should mention this in the cover letter so timed publication can be considered.

Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

What are the publication costs?

Authors can publish through subscription, open access, and free-to-access models depending on the journal and research funders.

Reformat to The Lancet Diabetes & Endocrinology using Livewrite Premium

Research Topics

Diabetes Management and Research Diabetes Treatment and Management Diabetes and associated disorders Diabetes, Cardiovascular Risks, and Lipoproteins Pancreatic function and diabetes Diet and metabolism studies Metabolism, Diabetes, and Cancer Global Public Health Policies and Epidemiology Obesity and Health Practices Bariatric Surgery and Outcomes Diabetes Management and Education Obesity, Physical Activity, Diet Pharmacology and Obesity Treatment Lipoproteins and Cardiovascular Health Nutritional Studies and Diet Bone health and osteoporosis research Birth, Development, and Health Gestational Diabetes Research and Management Vitamin D Research Studies Hormonal Regulation and Hypertension Hyperglycemia and glycemic control in critically ill and hospitalized patients Chronic Disease Management Strategies Thyroid Disorders and Treatments Pituitary Gland Disorders and Treatments Health Systems, Economic Evaluations, Quality of Life

Related Journals

JO
Journal of Obesity & Metabolic Syndrome Korean Society for the Study of Obesity
JO
Journal of Global Antimicrobial Resistance Elsevier BV
JO
Journal of Pain Elsevier BV
AO
Archives of Medical Research Elsevier BV
TI
Trends in Endocrinology and Metabolism Elsevier BV
EJ
European Journal of Endocrinology Oxford University Press